Title
CDMO Biopharmaceutical Contract Manufacturing | Goodwin Bio
Go Home
Category
Description
Goodwin Biotechnology is the preferred biologics CDMO partner. We help anticipate biopharmaceutical candidate challenges.
Address
Phone Number
+1 609-831-2326 (US) | Message me
Site Icon
CDMO Biopharmaceutical Contract Manufacturing | Goodwin Bio
Page Views
0
Share
Update Time
2022-08-11 16:12:43

"I love CDMO Biopharmaceutical Contract Manufacturing | Goodwin Bio"

www.goodwinbio.com VS www.gqak.com

2022-08-11 16:12:43

Skip to contentGoodwin Welcomes Darrin Schellin as CEO Learn More goodwin-final-color Color Goodwin logo Main Menu Manufacturing SolutionsShow submenuAnalytical Method DevelopmentClinical GMP Manufacturing ServicesUpstream DevelopmentDownstream DevelopmentAseptic Fill and FinishBioconjugationSupport SolutionsShow submenuRegulatory & CMC SupportQuality ControlQuality AssuranceProject ManagementBiotechnology Consulting ServicesCell Line DevelopmentApplicationsShow submenuCOVID-19ExosomesBiosimilars & BiobettersMultispecific Antibodies & Antibody FragmentsAboutShow submenuWho We AreLeadershipBoard of DirectorsFacilities and LocationWhy Goodwin Biotechnology?Goodwin AwardsCollaborations & PartnershipsGoodwin Biotechnology in the NewsShow submenuPress ReleasesUpcoming EventsIn the NewsPublications & PatentsCareersContact UsManufacturing SolutionsShow submenuAnalytical Method DevelopmentClinical GMP Manufacturing ServicesUpstream DevelopmentDownstream DevelopmentAseptic Fill and FinishBioconjugationSupport SolutionsShow submenuRegulatory & CMC SupportQuality ControlQuality AssuranceProject ManagementBiotechnology Consulting ServicesCell Line DevelopmentApplicationsShow submenuCOVID-19ExosomesBiosimilars & BiobettersMultispecific Antibodies & Antibody FragmentsAboutShow submenuWho We AreLeadershipBoard of DirectorsFacilities and LocationWhy Goodwin Biotechnology?Goodwin AwardsCollaborations & PartnershipsGoodwin Biotechnology in the NewsShow submenuPress ReleasesUpcoming EventsIn the NewsPublications & PatentsCareersContact UsGoodwin DeliversOn Time. On Budget. In Compliance.Goodwin Biotechnology’s mission is to eliminate the manufacturing risk for companies developing complex biologic therapeutics by being the pre-eminent provider of high-quality, cost-effective, flexible and timely cGMP compliant CDMO solution. From pre-clinical development through commercial product supply. By integrating our CDMO services in one location, Goodwin provides a Single Source Solution™ to anticipate and overcome the challenges you face with your biopharmaceutical candidate, whether it be complex proteins such as monoclonal antibodies or a sophisticated Antibody Drug Conjugate (ADC). Learn More About Our Mission Our SolutionsUnique & Unrivaled CDMO ExpertiseGoodwin offers a full scope of integrated services, ranging from cell line development, cell culture and purification process development, cell banking, scale up to manufacturing, and cGMP manufacturing with aseptic fill / finish from early- and late-stage clinical trials as well as commercialization for Monoclonal Antibodies, Vaccines, and Antibody Drug Conjugates (ADCs) including other bioconjugates.Manufacturing SolutionsSupport SolutionsApplicationsManufacturing SolutionsManufacturing SolutionsGoodwin offers a full range of mammalian cell culture services ranging from the creation of up and downstream processes through scale up and cGMP manufacturing of your biopharmaceutical candidate. We work with most cell lines used for manufacturing, including CHO, NSO, BHK, HEK293 as well as murine and human hybridomas, and all selection systems used with these cell lines such as dhfr-/methotrexate CHO, mycophenolic acid/xanthine, and G418 systems. Our experience includes surface dependent as well as suspension culture types. Explore Our Manufacturing Solutions Analytical Method Development Clinical GMP Manufacturing Services Upstream Development Downstream Development Aseptic Fill and Finish Bioconjugation Analytical Method Development Clinical GMP Manufacturing Services Upstream Development Downstream Development Aseptic Fill and Finish BioconjugationSupport SolutionsSupport SolutionsThe Manufacturing Solutions that Goodwin offers are fully supported by our analytical / method and formulation development capabilities as well as our quality control, quality assurance, regulatory, and project management capabilities. Explore Our Support Solutions Regulatory & CMC Support Quality Control Quality Assurance Project Management Biotechnology Consulting Services Cell Line Development Regulatory & CMC Support Quality Control Quality Assurance Project Management Biotechnology Consulting Services Cell Line DevelopmentApplicationsApplicationsGoodwin Biotechnology is dedicated to anticipating and overcoming challenges to provide solutions for biopharmaceutical projects and we retain flexibility in employing our services to address the ever-evolving CDMO needs of the biopharmaceutical industry. Explore Our Applications COVID-19 Exosomes Biosimilars & Biobetters Multispecific Antibodies & Antibody Fragments COVID-19 Exosomes Biosimilars & Biobetters Multispecific Antibodies & Antibody Fragments About UsTrust the CDMO with the longest experience in the business30 YEARS AND COUNTING…We offer a unique and unrivaled CDMO expertise in the research, development, validation and commercial scale manufacture of Antibody Drug Conjugates (ADCs), radioimmunoconjugates, complex proteins, and other protein bioconjugates. We have more than a decade of experience and multiple patents pending in protein modifications through chemical bioconjugation of cancer drugs, protein toxins, bifunctional ligands and metal chelates (for radio-isotope labeling), antibodies and other biological molecules onto monoclonal antibodies and recombinant proteins.Learn More About Our HistoryExperience Backed by Numbers 500 Different Projects 150 +Satisfied Clients 80 %Repeat Business 85 +Audits 50 +IND Filings Impact Stories Video Explore Goodwin’s Facilities SpotlightThe Latest from Goodwin BiotechnologyView All News & Events Read MoreNewsGoodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive OfficerFebruary 16, 2022 NewsAST and Goodwin Biotechnology Partner on a GENiSYS® C20 Aseptic Small Batch Filling & Closing MachineSeptember 14, 2020 NewsGigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant Hyperimmune Drug for COVID-19, GIGA-2050September 9, 2020 CareersJoin our team of highly skilled scientistsGoodwin Biotechnology has a long history of advancing the careers of dedicated scientists and other skilled professionals who thrive on providing solutions that help treat and monitor insidious diseases. To learn more about joining our great team, click here.Career Opportunities 1850 N.W. 69th Avenue Plantation, FL 33313 USA954-321-5300FacebookTwitterLinkedInManufacturing SolutionsShow submenuAnalytical Method DevelopmentClinical GMP Manufacturing ServicesUpstream DevelopmentDownstream DevelopmentAseptic Fill and FinishBioconjugationSupport SolutionsShow submenuRegulatory & CMC SupportQuality ControlQuality AssuranceProject ManagementBiotechnology Consulting ServicesCell Line DevelopmentApplicationsShow submenuCOVID-19ExosomesBiosimilars & BiobettersMultispecific Antibodies & Antibody FragmentsWho We AreShow submenuLeadershipBoard of DirectorsFacilities & LocationWhy Goodwin Biotechnology?Goodwin AwardsCollaborations & PartnershipsGoodwin Biotechnology in the NewsCareersBlog ©2022 Goodwin Biotechnology Inc. All Rights Reserved.Privacy PolicySitemap .wp-container-1 .alignleft { float: left; margin-right: 2em; }.wp-container-1 .alignright { float: right; margin-left: 2em; }